MedicarePartD.guide

A non-government resource built from CMS public data

Kisqali on SilverScript Choice (S5601-008)

ribociclib

Covered, with prior authorization required.

Tier 5 (specialty tier). No quantity limit.

25%
Patient pays / month, after deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

KISQALI 200 mg Tablet, Film Coated at a preferred retail pharmacy. Other covered strengths are listed below.

Prior authRequired on all 3 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 3 covered strengths and forms
FormTierPatient pays / monthLimits
KISQALI 200 mg Tablet, Film Coated525%PA
KISQALI 200 mg Tablet, Film Coated525%PA
KISQALI 200 mg Tablet, Film Coated525%PA

Other CDK4/6 inhibitors on this plan

Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5601-008